Cite
MLA Citation
Tobias Boch et al.. “Safety and efficacy of the CD95-ligand inhibitor asunercept in transfusion-dependent patients with low and intermediate risk MDS.” Leukemia research, vol. 68, 2018, pp. 62–69. http://access.bl.uk/ark:/81055/vdc_100059393366.0x000052